Peter Wolfe
Chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA) since December 2022
Peter Wolfe has filed 5 insider reports with the SEC since December 2022, as chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA). The latest filing, on July 15, 2025, reports grant or award at ZyVersa Therapeutics, Inc. (ZVSA).
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Peter Wolfe is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince December 2022 | 44,585 | Jul 15, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 11, 2025ZVSASEC Form 4 filed by Chief Financial Officer Wolfe PeterForm 4Grant or award
- May 24, 2023ZVSASEC Form 4 filed by Chief Financial Officer Wolfe PeterForm 4Grant or award
- Dec 16, 2022ZVSASEC Form 4: Wolfe Peter was granted 3,000 shares, increasing direct ownership by 7% to 44,585 unitsForm 4Grant or award
- Dec 12, 2022ZVSASEC Form 4: Wolfe Peter was granted 41,585 sharesForm 4Grant or award
- Dec 12, 2022ZVSAPeter Wolfe became an insiderForm 3New insider
Compare Peter Wolfe with
- Peter Wolfe vs Karen A. Cashmere1 shared
- Peter Wolfe vs James Sapirstein1 shared
- Peter Wolfe vs Stephen C. Glover1 shared
- Peter Wolfe vs Gregory Gene Freitag1 shared
- Peter Wolfe vs Robert G Finizio1 shared
- Peter Wolfe vs Pablo A. Guzman1 shared
Other insiders at the same companies
- Karen A. CashmereZVSA
- James SapirsteinZVSA
- Gregory Gene FreitagZVSA
- Pablo A. GuzmanZVSA
- Stephen C. GloverZVSA
- Robert G FinizioZVSA
- Min-Chul ParkZVSA
Questions about Peter Wolfe
- What is Peter Wolfe's role at ZyVersa Therapeutics, Inc.?
- Peter Wolfe reports to the SEC as chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA), according to the latest filing on July 15, 2025.
- How many shares does Peter Wolfe own?
- After the latest filing that states it, Peter Wolfe directly owned 44,585 shares of ZyVersa Therapeutics, Inc. (ZVSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter Wolfe bought or sold stock recently?
- No open-market purchases or sales by Peter Wolfe are on file. The filings report grant or award.
- How do I get alerts when Peter Wolfe files?
- Follow Peter Wolfe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Peter Wolfe (SEC CIK 0001954398). Totals count each trade once, skipping amendments whose original is on file, from Dec 13, 2022 on. View on SEC EDGAR